Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All HeartSciences Inc. filings on SEC EDGAR ↗
HeartSciences M&A Deal with Fortitude Mining Holdings, Inc.
HeartSciences Inc. filed an amendment to its 8-K regarding its pending merger with Fortitude Mining Holdings, Inc., a digital asset mining company. This filing provides updated interim financial statements and management's discussion for Fortitude for the nine months ended September 30, 2026. The update is a required step in the regulatory process to complete the previously announced business combination.
HeartSciences M&A Deal with Fortitude Mining Holdings, Inc.
HeartSciences Inc. provided a status update regarding its pending merger with Fortitude Mining HoldCo, LLC, a subsidiary of Digital Currency Group. The company issued supplemental proxy disclosures to address demand letters from purported shareholders alleging disclosure omissions, aiming to avoid potential litigation delays ahead of the November 19, 2026, shareholder vote.
HeartSciences received FDA 510(k) clearance for its MyoVista wavECG device as a 12-lead resting electrocardiograph for adult and pediatric patients. While the company does not intend to commercialize the device without a cleared AI-ECG algorithm, the approval broadens strategic options for the asset and its intellectual property. The company also noted its pending merger with Fortitude Mining Holdings remains on track to close in Q4 2026.
HeartSciences $500K Debt Financing with Front Range Ventures LLC
HeartSciences Inc. entered into Amendment No. 8 to its loan agreement with Front Range Ventures LLC to extend the maturity date of a $500,000 secured promissory note. The new maturity date is the earlier of January 29, 2027, or two business days following the closing of its proposed business combination with Fortitude Mining Holdings, Inc.